Health AI Startup Heidi Raises $340M at $900M Valuation
Australian health AI startup Heidi has closed a Series C round of $100 million, led by Blackbird, with participation from Phoenix Court, Point72 Private Investments, and Headline, valuing the company at $900 million. In parallel, Heidi secured $240 million in growth financing from General Catalyst's Customer Value Fund, a revenue-based instrument that covers sales and customer acquisition costs. Combined, these deals provide $340 million in fresh capital. The company has raised $436.6 million to date. Heidi, founded in Melbourne, started as an AI scribe for clinical documentation and now positions itself as an 'AI care partner'. It reports 2.8 million patient encounters per week across 190 countries. The funding will support regulatory work for advanced clinical features in Europe and the UK, and expansion in the DACH region.
- •Heidi closed a Series C round of $100 million, led by Blackbird, at a $900 million valuation.
- •Heidi secured $240 million in growth financing from General Catalyst's Customer Value Fund.
- •The combined funding of $340 million brings Heidi's total capital raised to $436.6 million.
